ARCHIVES

FDA, ASCO Meet to Review Drug Approval Endpoints

This article is from The Cancer Letter archive.

Vol. 29 No. 17 | April 25, 2003

Download PDF Visit The Full Archive

Related Articles

NCI advisors approve $144 million program for nanotechnology centers, R01 grants, training. Three to five consortia envisioned.

July 16, 2004

Surgery Improves Survival For Women With Metastatic Breast Cancer At Diagnosis

May 26, 2006

Neulasta Reduces Incidence Of Febrile Neutropenia

February 22, 2013

False-Positive Mammograms Can Indicate Higher Cancer Risk

April 27, 2012

HHS Says NIH Improperly Used Program For Scientists To Hire Administrators.

July 13, 2001

Seven Divisions Proposed, Separating Intramural, Extramural Programs

August 11, 1995